Navigation Links
Trovagene, Inc., Announces Fourth Quarter and Year End 2012 Earnings
Date:4/1/2013

on of transrenal DNA and RNA, short nucleic acid fragments, originating from normal and diseased cell death that cross the kidney barrier and can be detected in urine. Trovagene has a strong patent position as it relates to transrenal molecular testing. It has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing. In addition, it owns worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myeloid leukemia (AML) and mutations in the SF3B1 gene, which have been shown to be associated with chemotherapy response in chronic lymphocytic leukemia (CLL) patients.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or fourth party payer reimbursement; limited sales and marketing efforts and dependence upon fourth parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trovagene, Inc., Announces Third Quarter and Year to Date Earnings, Provides Milestone Update
2. Trovagene, Inc. Announces Second Quarter and Year to Date Earnings, Provides Milestone Update
3. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
4. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
5. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
6. Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.
7. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
8. New Avenues to Market - Research Report on Isis Pharmaceuticals, Inc., Avon Products, Inc., Elizabeth Arden, Inc., Boyd Gaming Corporation and Ameristar Casinos, Inc.
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Free Research Report on Laboratory Corp. of America Holdings, Sony Corp., Cyberonics, Inc., Olin Corp. and Deluxe Corp.
11. Free Research Report on Delta Air Lines, Inc., Johnson & Johnson, Barrick Gold Corp., Exelon Corp. and Cirrus Logic, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , Oct. 24, 2014 Burzynski Research ... and Drug Administration (FDA) has given the company permission ... AS2-1 in patients > 3 months of age with ... be placed in one of five treatment groups based ... received prior treatment for DIPG. The primary study endpoint ...
(Date:10/25/2014)... N.C. , Oct. 24, 2014  As ... can provide a company access to diverse skill ... markets, and round-the clock business hours for efficiency. ... difficult hurdles. According to recent ... disappointments, such as seeing a project not move ...
(Date:10/22/2014)...  Cephasonics, a technology-innovation leader with a game-changing embedded-ultrasound ... Ultrasound Box™-1), the first product in a new family ... Cephasonics for purchase by companies to rebrand with their ... showcasing the cQUB-1 for the first time at CMEF ... Chongqing, China from October 23 to 26. ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3
... April 27, 2011 ACCESS PHARMACEUTICALS, ... leveraging its proprietary drug-delivery platforms to develop treatments in areas ... Nursing Society (ONS) Congress at the Boston Convention and Exhibition ... (#652) will be displayed in the Exhibition Hall of the ...
... PharmaTech (Cayman) Inc. (NYSE: WX ) today ... 20-F for the year ended December 31, 2010 with ... be accessed on WuXi PharmaTech,s website at http://www.wuxiapptec.com ... provide a hard copy of its annual report on ...
Cached Medicine Technology:Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress 2Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress 3
(Date:10/25/2014)... WI (PRWEB) October 25, 2014 ... tax-advantaged medical and other benefits account management services, ... to help employers save on taxes, reduce administrative ... Suites provide tax savings and the efficient handling ... pick the Suite that best meets their goals ...
(Date:10/25/2014)... October 25, 2014 Market ... Diagnostics Industry, 2009-2019 is a professional and ... Molecular Diagnostics industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Molecular Diagnostics listing their product ...
(Date:10/25/2014)... 2014 Homeowners that are wondering how ... need wonder no more. Clean Crawls gives 5 ... out for when it comes to insulation in their ... article released by Clean Crawls, can cause problems throughout ... insulation that has deteriorated, become damp, or been infested ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 Mesothelioma researchers ... continued to receive pemetrexed (Alimta), after his combination drug ... the full story , just posted on the Surviving ... Uji Tokushukai Medical Center in Japan suggests that “maintenance ... mesothelioma patients who cannot tolerate higher doses of ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Interrupting blood supply to an arm ... risks associated with the surgery, according to a new study. ... blood supply to the heart to be able to operate ... will reduce its ability to produce energy because it doesn,t ... another large muscle, such as an arm or a leg, ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2
... tremors and other motor problems , FRIDAY, April 2 ... in a gene called LRRK2 may cause Parkinson,s disease ... using genetically engineered mice, the Mount Sinai School of ... controls motor performance. Dopamine is a neurotransmitter. The mutation ...
... -- In a move that could change the way ... state-of-the-art Siemens Artis zeego medical imaging systems that provide ... a quality never before attainable. With more complete information, ... detailed surgical plan, and provide more targeted surgical treatment. ...
... somewhere other than a crib , FRIDAY, April 2 (HealthDay ... die from sleep-related causes than infants in any other ethnic ... of Illinois, where the research was conducted, black infants ... Researchers in the Child Health Data Lab at Children,s Memorial ...
... ... True announces a partnership agreement with Agog Creative Group to become ... of music and spoken-word audio products. The Relaxation Company products include ... which have sold over one million copies. The Relaxation Company products ...
... ... new attention, blasting back at racist accusations leveled against the tea party movement ... Representatives Barney Frank, John Lewis and others. A major distribution deal and an ... is reaching even further into the mainstream debate. , ...
... users reveal misuse of antibiotics, including sharing leftover ... News) -- Medical misinformation can spread quickly on ... for sharing vital and correct health information, a ... and MixedInk in New York City identified more ...
Cached Medicine News:Health News:Operating room radiography to transform surgery 2Health News:Operating room radiography to transform surgery 3Health News:Sleep-Related Death Rate Higher Among Black Infants 2Health News:Sounds True Announces Licensing Partnership with The Relaxation Company, Becomes Market-Leader in Benefit-Oriented Sound Healing Music 2Health News:Sounds True Announces Licensing Partnership with The Relaxation Company, Becomes Market-Leader in Benefit-Oriented Sound Healing Music 3Health News:TEA PARTY MOVIE Goes Mainstream Blasting Racist Accusations from Left-wing Media and Big Government Politicians 2Health News:Medical Misinformation Can Spread Quickly Via 'Tweets' 2Health News:Medical Misinformation Can Spread Quickly Via 'Tweets' 3
... high-quality light guide cables work in conjunction ... optimal brightness during a number of procedures. ... you the flexibility and ease-of-use necessary to ... fully-autoclavable so they can be easily cleaned ...
... line of affordable, high-quality light guide cables ... sources to provide optimal brightness during a ... durable design give you the flexibility and ... And each is fully-autoclavable so they can ...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
Medicine Products: